At the time of the last dose administered, the difference in WURSS-21 total symptom domain score was −24.7 (95% CI: −27.73 to −21.67; p < 0.0001) compared with baseline, which represents a drop to a severity level between very mild and mild. A 64.8% improvement from baseline in WURSS-21 total symptom domain score was observed at the last dose of treatment needed for all participants completing the study (n = 100) [Figure 3(b) and Supplemental Table 2].